Bambus[4,6]urils as Dual Scaffolds for Multivalent Iminosugar Presentation and Ion Transport: Access to Unprecedented Glycosidase-Directed Anion Caging Agents.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
26 Jul 2022
Historique:
received: 29 06 2022
revised: 19 07 2022
accepted: 21 07 2022
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 30 7 2022
Statut: epublish

Résumé

Bambusurils, BU[4] and BU[6], were used for the first time as multivalent scaffolds to link glycosidases inhibitors derived from 1-deoxynojirimycin (DNJ). Two linear DNJ ligands having six or nine carbon alkyl azido linkers or a trivalent DNJ dendron were grafted onto octapropargylated BU[4] and dodecapropargylated BU[6] using copper-catalyzed cycloaddition (CuAAC) to yield corresponding neoglycobambus[4] and neoglycobambus[6]urils bearing 8 to 24 iminosugars. The inhibition potencies of neoglycoBU[4], neoglycoBU[6] and neoglycoBU[6] caging anions were evaluated against Jack Bean α-mannosidase and compared to monovalent DNJ derivatives. Strong affinity enhancements per inhibitory head were obtained for the clusters holding trivalent dendrons with inhibitory constants in the nanomolar range (

Identifiants

pubmed: 35897947
pii: molecules27154772
doi: 10.3390/molecules27154772
pmc: PMC9330389
pii:
doi:

Substances chimiques

Anions 0
Enzyme Inhibitors 0
Imino Sugars 0
1-Deoxynojirimycin 19130-96-2
Glycoside Hydrolases EC 3.2.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : University of Strasbourg
ID : no
Organisme : Centre National de la Recherche Scientifique
ID : no
Organisme : CEA
ID : no
Organisme : Chinese scholarship council
ID : no
Organisme : icFRC
ID : PCO-003-2016

Références

Chemistry. 2018 Jul 25;24(42):10793-10801
pubmed: 29722918
Arch Pharm (Weinheim). 2022 Mar;355(3):e2100405
pubmed: 34862650
Org Lett. 2013 Feb 1;15(3):480-3
pubmed: 23320891
Chem Commun (Camb). 2020 May 14;56(39):5207-5222
pubmed: 32322844
Anal Chim Acta. 2017 Jan 15;950:49-56
pubmed: 27916129
Chem Commun (Camb). 2017 Jul 4;53(54):7557-7560
pubmed: 28634604
Chemistry. 2018 Feb 16;24(10):2483-2492
pubmed: 29281149
Chem Commun (Camb). 2014 Mar 28;50(25):3350-2
pubmed: 24535213
Chemistry. 2021 Feb 10;27(9):3142-3150
pubmed: 33150981
Chempluschem. 2015 Nov;80(11):1601-1606
pubmed: 31973379
Eur J Med Chem. 2014 Mar 3;74:302-13
pubmed: 24480360
Chemistry. 2016 Sep 5;22(37):13147-55
pubmed: 27516128
Chembiochem. 2014 Jun 16;15(9):1239-51
pubmed: 24807298
Molecules. 2021 Sep 27;26(19):
pubmed: 34641408
Org Lett. 2011 Aug 5;13(15):4000-3
pubmed: 21707115
Angew Chem Int Ed Engl. 2018 Jul 2;57(27):8002-8006
pubmed: 29722924
Chemistry. 2011 Dec 2;17(49):13825-31
pubmed: 22052823
Chemistry. 2014 Sep 8;20(37):11616-28
pubmed: 25081380
Angew Chem Int Ed Engl. 2010 Aug 2;49(33):5753-6
pubmed: 20818758
Chem Commun (Camb). 2015 Mar 18;51(22):4666-9
pubmed: 25690137
J Nucl Med. 1996 Sep;37(9):1504-10
pubmed: 8790202
Pharmaceuticals (Basel). 2020 Nov 05;13(11):
pubmed: 33167387
Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1680-1685
pubmed: 29630112
Org Biomol Chem. 2009 Jan 21;7(2):357-63
pubmed: 19109682
RSC Adv. 2019 Nov 1;9(61):35452-35455
pubmed: 35528105
Endocr Relat Cancer. 2021 Sep 03;28(10):T125-T140
pubmed: 34254949
Chembiochem. 2013 Oct 11;14(15):2038-49
pubmed: 24014313
Chem Rec. 2020 Jan;20(1):10-22
pubmed: 30993894
Org Lett. 2020 Apr 17;22(8):3099-3103
pubmed: 32243185
Angew Chem Int Ed Engl. 2010 Mar 22;49(13):2378-81
pubmed: 20217882
ACS Omega. 2018 Jan 31;3(1):1231-1243
pubmed: 29399654
Org Lett. 2020 Feb 21;22(4):1633-1637
pubmed: 32023070
Chemistry. 2012 Jan 9;18(2):641-51
pubmed: 22147564
J Am Chem Soc. 2013 Dec 11;135(49):18427-35
pubmed: 24224682
Org Lett. 2020 Jan 3;22(1):204-208
pubmed: 31846336
J Am Chem Soc. 2017 Feb 22;139(7):2597-2603
pubmed: 28222609
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794
pubmed: 29711117
Chemistry. 2016 Apr 4;22(15):5151-5
pubmed: 26917097
Bioconjug Chem. 2015 Apr 15;26(4):766-72
pubmed: 25741759
Carbohydr Res. 2016 Jun 24;429:123-7
pubmed: 26852253

Auteurs

Marine Lafosse (M)

Département Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SCBM, 91191 Gif-sur-Yvette, France.

Yan Liang (Y)

Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), Laboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg|University of Haute-Alsace|CNRS (UMR 7042), 67087 Strasbourg, France.

Jérémy P Schneider (JP)

Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), Laboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg|University of Haute-Alsace|CNRS (UMR 7042), 67087 Strasbourg, France.

Elise Cartier (E)

Département Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SCBM, 91191 Gif-sur-Yvette, France.

Anne Bodlenner (A)

Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), Laboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg|University of Haute-Alsace|CNRS (UMR 7042), 67087 Strasbourg, France.

Philippe Compain (P)

Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), Laboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg|University of Haute-Alsace|CNRS (UMR 7042), 67087 Strasbourg, France.

Marie-Pierre Heck (MP)

Département Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SCBM, 91191 Gif-sur-Yvette, France.

Articles similaires

Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Cryoelectron Microscopy Ribonucleotide Reductases Escherichia coli Catalytic Domain Cytidine Diphosphate
Carps Animals Mercury Magnetic Fields Water Pollutants, Chemical
Thiosemicarbazones Monophenol Monooxygenase Quantitative Structure-Activity Relationship Molecular Dynamics Simulation Drug Design

Classifications MeSH